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Yue-Li Xing 1 *, Yan-Chun Wang 2 complementary therapy for clinical operations, which can strengthen oxygen-carrying ability of cells and supplement blood volume and the colloid ingredients and coagulation factors of blood. However, there are still many blood transfusion associated complications, like hemolysis, fever, allergy, immunosuppression and infectious diseases induced by virus and bacteria, etc.. As early as 1970s, studies have showed that homologous blood transfusion can lead to blood-transfusion connected immunosuppression (Opelzet al., 1973) and prei-operative blood transfusion can increase the recurrence rate of tumors (Amato et al., 2006) . It is estimated that about 0.2% blood receptors have showed inflammatory responses marked by systematic inflammatory response syndrome due to blood transfusion, which can trigger serious septicemia, lung failure and multiple organ failures (Urner et al., 2012) . Therefore, blood protection technique receives more and more attentions recently. As one of the blood protection techniques, autologous blood transfusion is gradually applied as a complementary therapy in clinical operation because it can not only avoid various transmission diseases due to blood transfusion, but also prevent homogeneous homologous blood transfusion induced homogeneous immunological responses. However, the influence of autologous blood transfusion on the immunological function of human body is still controversial. In order to explore the influence of different ways of blood transfusion on immunological functions of patients with esophagus carcinoma, this study detected the dynamic changes of inflammatory factors such as interleukins (IL) and tumor necrosis factor-α (TNF-α), hoping to provide theoretical basis for the rational application of blood transfusion in peri-operative patients with esophagus carcinoma.
Materials and Methods
General data
A total of 80 patients who were diagnosed with esophagus carcinoma by gastroendoscope and histopathological detection and received radical operations were selected as study objects, in which there were 44 males and 36 females, aged from 32 years to 68 years, with mean age being (49.15±7.23) years. Inclusion criteria: Predicative hemorrhage volume>500 mL; American Society of Anesthesiologists (ASA): phase Ⅰ~Ⅱ; With well functions of heart and lung; Without hepatorenal function damage and metabolic, respiratory and immunological system diseases; Without drugs that could affect immunological function in peri-operative period, like corticosteroid; Without virus and bacterial infection and without fever before operation. The patients were randomly divided into observation group and control group, 40 cases for each group. There were significant differences in general data such as genders, ages, tumor histological types and patterns (P>0.05), which were comparable.
All therapeutic measures were approved by ethics committees and conducted after Informed Consent Forms were signed by patients or their families.
Methods
Anesthesia method: General anesthesia was adopted in both groups. Induction routine of intravenous anesthesia: fentanyl 2 μg/kg, midazolam 0.04 mg/kg, propofol 1.5 mg/kg and vecuronium bromide 0.12 mg/kg. Anesthesiamaintenance: continuous intravenous injection of fentanyl 0.1~0.2 mg/ (kg·min) and remifentanil 0.05~0.2 mg/ (kg·min). Patient-controlled analgesia: intravenous injection of fentanyl 6~8 μg/mL.
Blood transfusions: Observation group was treated with autologous blood transfusion, for which blood tests were given immediately after patients were hospitalized, and 400 mL autologous blood was collected in advance from patients with hemoglobin (Hb) >110 g/L one week before operation and then stored at 4℃ for utilization. After operations were started, full automatic blood salvage machine (Type: Cell Saver-5, produced by American Haemonetics company) was used to absorb the lost blood in operative field during operation. Meanwhile, 30 000 μ/1 000 mL normal saline (NS) containing heparin was added at 60 drops/min for anti-coagulation. Then the blood was filtered, washed, centrifuged and stored in blood bag for use. The blood was used when HB<100 g/L and hematocrit value (Hct) <0.3. Control group was given appropriate homologous blood according to the hemorrhage volume and vital sign of patients, in which autologous blood was not collected in advance before operation and no lost blood in operative field was recovered during operation.
Sample collection and detection
Sample collection: 5 mL fasting venous blood 1 d before operation and 1, 5 and 7 d after operation was collected and centrifuged at 3500 r/min for 15 min at 4℃. Supernatant was collected and stored at -80℃ for utilization. Sample detection: Double-antibody enzyme-linked immunosorbent assasy (ELISA) was adopted to detect inflammatory factors, such as interleukin-6 (IL-6), IL-8, IL-10 and tumor necrosis factor-α (TNF-α). ELISA imark (American Bio-Rad Company) was applied with all kits being purchased from Cell-Bio Biotechnology Co., Ltd. All procedures were conducted strictly according to the instructions on kits.
Observational indexes
Intra-operative indexes (hemorrhage volume, fluid infusion volume and blood transfusion volume), peripheral blood indexes (Hb, Hct and WBC) and peri-operative inflammatory factors (IL-6, IL-8, IL-10 and TNF-α) in both groups were observed.
Statistical data analysis SAS 9.3 software package was applied for all data analysis. Measurement data was expressed by (x±s), in which measurement data with normal distribution between two groups was compared by t-test while those with nonnormal distribution between two groups by rank-sum test, and comparisons among multiple groups by Chi-squared test. P<0.05 was considered to be statistically significant.
Results
Comparisons of intra-operative indexes between two groups
Operations for patients of both groups were successfully completed, and there was no significant difference in mean surgical duration and intra-operative hemorrhage volume, fluid infusion volume and blood transfusion volume (P>0.05) ( Table 1) .
Changes of peripheral blood before and after operations in both groups
Compared with operation before, Hb and Hct levels decreased evidently while WBC increased markedly 1, 5 and 7 d after operation (P<0.05, P<0.01). In addition, WBC was apparently higher in observation group than in control group 5 and 7 d after operation (P<0.01). However, DOI:http://dx.doi.org/10.7314/APJCP.2014.15.18.7831 Blood Transfusion and Interleukins and Tumor Necrosis Factor-α the indexes at other time points had no significant differences between two groups (P>0.05) ( Table 2) .
Changes of inflammatory factors before and after operations in both groups
Compared with operation before, in observation group, IL-6, IL-8 and IL-10 levels had no significant differences after operation (P>0.05) whereas TNF-α level increased gradually after operation and reached its peak 5 d after operation and then the level began to decrease, but was still evidently higher than operation before (P<0.01). Compared with operation before, in control group, IL-6 level had no significant difference (P>0.05), IL-8 level decreased obviously (P<0.05, P<0.01), IL-10 level increased markedly and then decreased gradually, but was still higher than the level before operation (P<0.01), and TNF-α level increased gradually after operation and reached its peak 1 d after operation, which was still evidently higher than the level before operation (P<0.01), then the level decreased gradually and there was no significant difference between the level 7 d after operation and that before operation (P>0.05). Comparison between two groups showed that there was no significant difference in IL-6 level at each time points (P>0.05), whereas the differences were significant in the rest indexes between at each synchronous time points (P<0.01) ( Table 3) .
Discussion
At present, treatments for multiple cancers (including esophagus carcinoma) mainly focus on surgical excision (Chen et al 2013; Zhang et al 2013; Tatematsu et al 2013) , but the general anesthesia, surgical therapies and traumas induced postoperative stress responses can trigger postoperative immunological dysfunction to cancer patients, which may aggravate the existed immunosuppression (Guo et al., 2014) . In addition, intra-operative blood transfusion is an indispensible complementary therapy due to the large traumas, longer duration and more hemorrhage volume in the operations for cancer patients, which can immediately remedy the intraoperative anemia and insufficient blood volume. However, blood transfusion-associated immunosuppression may further aggravate the postoperative immunosuppression of cancer patients, which will enable residual and exfoliative tumor cells escape from immunological surveillance, leading to recurrence and distant metastasis of tumors (De Oliveira et al., 2012; Meng et al., 2013) . A study found that autologous blood transfusion could improve the postoperative immunological function and protect organs of cancer patients (Han et al., 2011; Stachura et al., 2011) . This study mainly detect the dynamic changes of IL-6, IL-8, IL-10 and TNF-α levels before and after operations so as to explore the influence of autologous and homologous blood transfusions on the immunological function of patients with esophagus carcinoma.
TNF-α and interleukins are important cellular factors in human body. TNF-α has multiple biological activities, which involves in inflammatory and immunological responses and has anti-tumor immunological functions. Meanwhile, it also participates in pathological processes such as endotoxin shock. Additionally, TNF-α also has multiple functions of anti-inflammation and killing tumor cells due to its synergistic action with other bioactive factors (Chen et al., 2010; Fujiwara et al., 2013; Su et al., 2013) . Previous research discovered that TNF-α could kill the residual tumors through inducing cell apoptosis, and many anti-tumor agents (cisplatin, etc.) could achieve their anti-tumor action by increasing TNF-α level (Kondo et al., 2006) . IL-10 can inhibit the proliferation transplantation and immune damage effect of human body to tumors via suppressing multiple cytokines that could kill tumor cells. In addition, IL-10 could also improve the metastasis and proliferation of tumors by strengthening the immuniological escape function of tumor cells (O'Garra et al., 2008) . IL-6 and IL-8, as two critical cytokines in activating anti-inflammatory responses, can promote the exudation and chemotixas of inflammatory cells and activate inflammatory cells, the increase of whose activities could inhibit and remove bacteria and increase the patients' anti-inflammatory and wound-healing abilities.
In this study, two blood transfusion methods were applied to reduce the rate of homologous blood transfusion in patients with atuologous blood transfusion, which meant the autologous blood salvage technique in predeposited autotransfusion. The results demonstrated that TNF-α level increased evidently after operation in observation group, which might be of great significance for the anti-tumor effect of human body. However, IL-10 level increased markedly in control group, especially 1 d after operation, and the level at each time points was apparently higher than that in observation group at the same time point, which might inhibit the activation of T lymphocytes, and even suppress the release of some cytokines, bringing about decreased immunological surveillance function of human body. Simultaneously, IL-8 level decreased obviously in control group, suggesting that the immunological function was inhibited to some extent in patients with esophagus carcinoma. Previous study indicated that autologous blood transfusion could increase IL-6 level (Schroeder et al., 2007) . But in this study, IL-6 level had no significant difference before and after operations in both groups, which was predicated to be associated with the study objects because the cancer patients themselves had certain degree of immunological dysfunction, but the influence of autologous blood transfusion on IL-6 level in patients with esophagus carcinoma needs to be further studied.
To sum up, the decreased IL-8 level and increased IL-10 level are critical potential factors inducing immunosuppression after homologous blood transfusion, and autologous blood transfusion can alleviate immunosuppression while increase TNF-α level, which may improve the anti-tumor effect of patients with esophagus carcinoma.
